Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects
Clinical trial NCT02243098 · COMPLETED
Trial details
- NCT number
- NCT02243098
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-16
- Primary completion
- 2015-04-07
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.